# CRC Post-surgical Assessment and Recurrence Monitoring

> **NCT03334890** · — · UNKNOWN · sponsor: **BioChain (Beijing) Science and Technology, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** plasma mSEPT9 level

## Key facts

- **NCT ID:** NCT03334890
- **Lead sponsor:** BioChain (Beijing) Science and Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-11-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334890, "CRC Post-surgical Assessment and Recurrence Monitoring". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03334890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*